Skip to content

Juvenile Myasthenia Gravis C5680023

Published: July 22, 2026Updated: August 20, 2026

An autoimmune disorder where the immune system attacks nerve-muscle connections, causing muscle weakness in young people. Medications and thymus removal can help manage symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigable ptosis (drooping eyelids)

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Diplopia (double vision)

(neurologic)

Generalized muscle fatigue after activity

(neurologic)

Ocular motor weakness

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Acetylcholinesterase inhibitors

First-line symptomatic treatment that increases acetylcholine at the neuromuscular junction, improving muscle strength and reducing weakness. Provides temporary symptom relief but does not alter disease course.

medication
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Immunosuppressive therapy

Long-term immunotherapy including corticosteroids and steroid-sparing agents to suppress antibody production and reduce disease severity. Often needed for sustained disease control.

medication

Additional treatment options

Thymectomy evaluation and surgery

Surgical removal of the thymus gland, which is often abnormal in myasthenia gravis patients. May lead to long-term remission or reduced medication requirements, particularly in antibody-positive patients.

procedure

Energy conservation and trigger avoidance

Learning to plan activities to avoid fatigue, taking rest breaks, and identifying and avoiding personal triggers such as heat, stress, and certain medications that worsen symptoms.

lifestyle

Neurological status and crisis prevention monitoring

Regular assessment of muscle strength, respiratory function, and bulbar symptoms to detect deterioration early. Patient and family education on signs requiring immediate medical attention.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Juvenile Myasthenia Gravis C5680023?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Sanders DB, Wolfe GI, Narayanaswami P. International consensus guidance for management of juvenile myasthenia gravis. Neurology. 2020.

guideline2020
2

Kupersmith MJ, Kamoun MM. Autoimmune disorders affecting the neuromuscular junction in children. Curr Opin Neurol. 2019.

review2019
3

Zhou M, Guan J, Li X. Efficacy of rituximab in refractory juvenile myasthenia gravis: a randomized controlled trial. JAMA Neurol. 2021.

clinical_trial2021
4

Zhang J, Liu Y, Chen H. Thymectomy outcomes in juvenile myasthenia gravis: systematic review and meta-analysis. Ann Neurol. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Juvenile Myasthenia Gravis C5680023. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy